Fig. 3
From: Multi-pathway targeted therapy of MASH-HCC using miR-22
Molecular signatures affected by miR-22 in MASH-HCC and HCC based on the location. Venn diagrams showing expressed gene numbers altered by miR-22 in MASH-HCC and HCC. Pathway analyses were performed using Reactome with significant pathways identified (FDR cutoff: 0.1, minimum fold change of 1.5) across three tissue regions: A inside the tumor, B at the tumor margin, and C outside the tumor areas